![Ben T. G. Tan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ben T. G. Tan
No open positions remaining
Profile
Ben T.
G.
Tan formerly worked at Novartis AG, as Director-Global Program Strategic from 2008 to 2011, Evolva SA, as Director-Business Development Pharmaceuticals from 2012 to 2014, N.V.
Organon, as Head-Global Licensing from 1997 to 2000, deVGen NV, as Executive Vice President-Business from 2000 to 2001, Speedel Pharma AG, as Head-Business Development from 2001 to 2008, ObsEva SA, as Vice President-Commercial & Business Development from 2014 to 2022, and Roche Netherlands BV, as Head-Medical Marketing from 1990 to 1993.
Mr. Tan received his graduate degree from Vrije Universiteit Amsterdam.
Former positions of Ben T. G. Tan
| Companies | Position | End |
|---|---|---|
| OBSEVA SA | Corporate Officer/Principal | 01/02/2022 |
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Corporate Officer/Principal | 01/03/2014 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2011 |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Corporate Officer/Principal | 01/01/2008 |
deVGen NV
 deVGen NV BiotechnologyHealth Technology Provides biotechnology services for the pharmaceutical and agrochemical industries | Corporate Officer/Principal | 01/01/2001 |
Education of Ben T. G. Tan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Health Technology |
deVGen NV
deVGen NV BiotechnologyHealth Technology Provides biotechnology services for the pharmaceutical and agrochemical industries | Health Technology |
Vrije Universiteit Amsterdam
 Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cardiovascular and metabolic diseases | Health Technology |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company focused on the research, development and commercialization of ingredients based on nature | Commercial Services |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
Roche Netherlands BV
 Roche Netherlands BV Medical DistributorsDistribution Services Wholesales pharmaceuticals and diagnostics products | Distribution Services |
- Stock Market
- Insiders
- Ben T. G. Tan
